© 2024 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.

Advertisement
<< Back To Article
PARP Inhibitors as New Standard of Care for More Ovarian Cancers

Write a Comment

I have read and agree to the terms and conditions in the Posting Rules*

1 Comments

M. Phillips

I am a Braca2+ pt in a clinical trialvtesting this drug for pancreatic ca pt. I am on my 32 cycle of this trial. I am doing well. There is some hope shown here.

February 19, 2019 • Virginia

Hot topics

Breast Cancer
Lung Cancer
Liver Cancer
Prostate Cancer
Cancer Treatment
FIT test, colon cancer screening
Cancer Screening
Ovarian Cancer
Blood Cancers - Leukemia/Lymphoma/Multiple Myeloma

Cancer Health uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. Our Privacy Policy

Manage

Cancer Health uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. By remaining on our website, you indicate your consent to our Privacy Policy and our Cookie Usage.